RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Open accessThe DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
RUNX1 is a transcription factor that regulates critical processes in many aspects of hematopoiesis. RUNX1 is also integral in defining the definitive hematopoietic stem cell. In addition, many hematological diseases like myelodysplastic syndrome and myeloproliferative neoplasms have been associated with mutations in RUNX1. Located on chromosomal 21, the RUNX1 gene is involved in many forms of chromosomal translocations in leukemia. t(8;21) is one of the most common chromosomal translocations found in acute myeloid leukemia (AML), where it results in a fusion protein between RUNX1 and ETO. The RUNX1-ETO fusion protein is found in approximately 12% of all AML patients. In this review, we detail the structural features, functions, and models used to study both RUNX1 and RUNX1-ETO in hematopoiesis over the past two decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Mutations affecting segment number and polarity in Drosophila
Nüsslein-Volhard, C., & Wieschaus, E. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370 · cited 1×
“encoded by the Drosophila runt gene, which is required for normal segmentation, sex determination, and neurogenesis during Drosophila embryogenesis (2-4).”
BackgroundValproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887 · cited 1×
“Valproic acid, another HDAC inhibitor, has also been shown to promote the differentiation of Kasumi cells, a t(8,21)-positive AML cell line (170).”
BackgroundOkuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856 · cited 1×
“One of the most important pieces of evidence implicating the role of RUNX1 in specifying the HSC was the generation of Runx1-null mice (64,65).”
BackgroundInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“The Mx1 gene is an interferon-inducible gene and its promoter allows expression of Cre to occur in HSCs when exposed to interferon (IFN) or other IFN-inducing agents like the synthetic double-stranded RNA polyinosinic/polycytidylic acid (polyIC) (73).”
BackgroundDefinitive Hematopoiesis Is Autonomously Initiated by the AGM Region
Medvinsky, A., & Dzierzak, E. (1996) · Cell · doi:10.1016/s0092-8674(00)80165-8 · Cited by 1,548 · cited 1×
“5 days post conception (dpc) in the mouse embryo, where they bud off from the ventral aspect of the dorsal aorta and eventually colonize the fetal liver (61,62).”
BackgroundPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370 · cited 1×
“Another study looked at 285 samples from patients with various types of AML and were able to place t(8,21)-positive patients into a unique cluster based on their gene profiles alone (163).”
BackgroundA complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214 · cited 6×
“These studies point toward the ability of RUNX1-ETO to recruit HDACs as a major mechanism that may give it its leukemogenic properties, and suggest that the use of HDAC inhibitors may be a potentially useful therapy for patients suffering from t(8,21)-positive AML.”
BackgroundInfluentialOncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187 · cited 1×
“The three most common chromosomal translocations involving RUNX1 are: t(8,21), t(12,21), and t(3,21) (105).”
BackgroundSong, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100 · cited 4×
“While haploinsufficiency of RUNX1 may predispose patients to FPD/AML, biallelic mutations in RUNX1 resulting from a second hit may lead to full on leukemia (96).”
BackgroundInfluential
Cited by
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
Grimwade, D., Ivey, A., & Huntly, B. J. P. (2016) · Blood · doi:10.1182/blood-2015-07-604496 · Cited by 445
The RUNX1–PU.1 axis in the control of hematopoiesis
Imperato, M. R., Cauchy, P., Obier, N., & Bonifer, C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1762-8 · Cited by 94
Conditional deletion of Ahr alters gene expression profiles in hematopoietic stem cells
Bennett, J. A., Singh, K. P., Welle, S. L., Boule, L. A., Lawrence, B. P., & Gasiewicz, T. A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0206407 · Cited by 25
Metadata
- Authors
- Lam, K.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2012
- Volume
- 17
- Issue
- 1
- Pages
- 1120
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/3977
- OpenAlex
- W2068180510
- Cited by
- 167
- References
- 178
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.